Cargando…
Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report”
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807329/ https://www.ncbi.nlm.nih.gov/pubmed/36605697 http://dx.doi.org/10.1002/iju5.12553 |
_version_ | 1784862698047012864 |
---|---|
author | Hatano, Koji |
author_facet | Hatano, Koji |
author_sort | Hatano, Koji |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9807329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98073292023-01-04 Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report” Hatano, Koji IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2022-11-08 /pmc/articles/PMC9807329/ /pubmed/36605697 http://dx.doi.org/10.1002/iju5.12553 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Comment Hatano, Koji Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report” |
title | Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report” |
title_full | Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report” |
title_fullStr | Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report” |
title_full_unstemmed | Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report” |
title_short | Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report” |
title_sort | editorial comment on “recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: a case report” |
topic | Editorial Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807329/ https://www.ncbi.nlm.nih.gov/pubmed/36605697 http://dx.doi.org/10.1002/iju5.12553 |
work_keys_str_mv | AT hatanokoji editorialcommentonrecurrentmultiplelivermetastasesofclearcellrenalcellcarcinomawithasignificantresponsetosunitinibafternivolumabtreatmentacasereport |